Approximately 3.5 billion individuals, nearly half the world’s population are at risk of malaria.  Sanaria’s long-term goal is to immunize populations through mass vaccination programs and use our vaccines in conjunction with standard control measures to halt transmission and eliminate malaria, including drug-resistant malaria, through focal and regional elimination campaigns.

Our short-term goals include preventing malaria in individuals including pregnant women, and young and school age children, especially during seasonal vaccination campaigns.

There are approximately 250 million individuals, such as tourists, diplomats, aid workers, expatriate workers, and military personnel, who travel to malaria endemic areas each year.  The highest risk group of travelers are the >40 million travelers that visit sub-Saharan Africa each year. Our goal is to provide a vaccine that will confer high level protection to travelers on short to medium term (3-12 weeks) trips to areas where they are at risk of exposure to Pf-transmitting mosquitoes.